ReviewPharmacoEconomics1996

Cefpodoxime proxetil. An appraisal of its use in antibacterial cost-containment programmes, as stepdown and abbreviated therapy in respiratory tract infections.

J A Balfour et al.PubMed ↗Publisher ↗

No numbers read from the abstract.